财通资管创新医药混合C(019741)资产负债表
| |
2025-06-30 |
2024-12-31 |
2024-06-30 |
| 资产 |
| 银行存款 |
- |
- |
- |
| 结算备付金 |
458,876.96 |
482,478.61 |
524,360.31 |
| 存出保证金 |
23,104.27 |
74,804.70 |
37,921.42 |
| 交易性金融资产 |
17,676,650.00 |
14,413,822.00 |
21,285,207.00 |
| 其中：股票投资 |
17,676,650.00 |
14,413,822.00 |
21,285,207.00 |
| 债券投资 |
- |
- |
- |
| 资产支持证券投资 |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
| 买入返售金融资产 |
- |
-57.20 |
53,513,727.00 |
| 应收证券清算款 |
2,206,520.32 |
822,114.40 |
- |
| 应收利息 |
- |
- |
- |
| 应收股利 |
- |
- |
- |
| 应收申购款 |
472,028.34 |
10,099.99 |
36,777,919.01 |
| 其他资产 |
- |
- |
- |
| 资产总计 |
22,118,158.96 |
16,707,959.36 |
180,047,237.77 |
| 负 债 |
| 短期借款 |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
| 应付证券清算款 |
1,600,933.32 |
132,389.48 |
7,065,689.53 |
| 应付赎回款 |
862,042.42 |
146,227.81 |
355,758.23 |
| 应付管理人报酬 |
16,356.04 |
18,499.77 |
69,919.31 |
| 应付托管费 |
2,726.02 |
3,083.28 |
11,653.22 |
| 应付销售服务费 |
3,642.54 |
2,365.99 |
16,949.94 |
| 应付交易费用 |
- |
- |
- |
| 应交税费 |
- |
- |
- |
| 应付利息 |
- |
- |
- |
| 应付利润 |
- |
- |
- |
| 其他负债 |
40,076.52 |
177,222.43 |
134,552.18 |
| 负债合计 |
2,525,776.86 |
479,788.76 |
7,654,522.41 |
| 所有者权益 |
| 实收基金 |
16,674,972.05 |
16,637,401.98 |
176,933,091.60 |
| 未分配利润 |
2,917,410.05 |
-409,231.38 |
-4,540,376.24 |
| 所有者权益合计 |
19,592,382.10 |
16,228,170.60 |
172,392,715.36 |
| 负债及所有者权益总计 |
22,118,158.96 |
16,707,959.36 |
180,047,237.77 |
欢迎访问证券之星！请点此与我们联系 版权所有： Copyright © 1996-年
微信公众号
证券之星APP
基本资料
